Top Markets
Coin of the day
Skye Bioscience, Inc. Skye Bioscience, Inc.

Skye Bioscience, Inc.

SKYE
Rank in Stocks #31149
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
Share Price
$0.38
Market Cap
$13.35M
Change (1 day)
-8.46%
Change (1 year)
-88.79%
Country
US
Trade Skye Bioscience, Inc. (SKYE)

Category

Stock price history for Skye Bioscience, Inc. (SKYE)
Highest end of day price: $0.49 on 2026-08-01

Lowest end of day price: $2.50K on 2014-11-01
Stock price history of Skye Bioscience, Inc. from 2014 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 27.55%
2025 -68.43%
2024 7.82%
2023 -19.28%
2022 -74.81%
2021 58.02%
2020 -81.19%
2019 -44.44%
2018 157.69%
2017 -64.63%
2016 -42.36%
2015 -92.76%
2014 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$531.75 36.39%
US
$1.00K 51.66%
NL
$111.31 -36.83%
AU
$735.86 6.87%
CH
$257.75 13.01%
BE